Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 412-413
DOI: 10.1111/apt.70625 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-03-17. Written by D Bogatic and 2 co-authors. Institution: Inflammatory Bowel Disease Service, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia. Cited 1 times so far (Crossref); 6 references. The full text is freely available in PubMed Central.
Abstract (original language)
Intet abstract tilgængeligt.
Authors and institutions
- Inflammatory Bowel Disease Service, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
- Inflammatory Bowel Disease Research Group, The Basil Hetzel Institute for Translational Health Research, Adelaide, South Australia, Australia.
- College of Health, Adelaide University, Adelaide, South Australia, Australia.
ORCID profiles: D Bogatic
Cite
APA
Bogatic, D., Costello, S. P., & Bryant, R. V. (2026). Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Alimentary Pharmacology & Therapeutics, 64(3), 412-413. https://doi.org/10.1111/apt.70625
Vancouver
Bogatic D, Costello SP, Bryant RV. Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Alimentary Pharmacology & Therapeutics. 2026;64(3):412-413. doi:10.1111/apt.70625
BibTeX
@article{Bogatic2026,
author = {Bogatic, D and Costello, S P and Bryant, R V},
title = {Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {3},
pages = {412--413},
doi = {10.1111/apt.70625}
}
EUVIMED